illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Tecan Group
Company logo

Tecan Group | Sustainability Performance

https://www.tecan.com/

Provider of laboratory instruments, automation solutions, and related services for life sciences and diagnostics.

1980

Switzerland

1,001 - 5,000 employees

Biotechnology

$1B - 10B in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#2681
Overall
#88
in Switzerland
#44
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

52 out of 244

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
Ypsomed

Switzerland, Health Care, Medical Device

Company logo
Galderma

Switzerland, Health Care, Pharmaceuticals

Company logo
Siegfried

Switzerland, Health Care, Pharmaceuticals

Market cap

2.0B $, 2026▲4.9% YoY

Revenue

882.0M $, 2025▲5.9% YoY

R&D intensity

5.78% 2025

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Tecan Group AG, Swiss/US life sciences instruments, has faced multiple US class actions over alleged inadequate disclosure of US biopharma customer demand normalization following the contested 2024 sustained share price volatility amid the postCOVID life sciences automation market normalization affecting Swiss institutional shareholders.
Powered by illuminem

Market cap

2.0B $, 2026▲4.9% YoY

Revenue

882.0M $, FY2025▲5.9% YoY

EBITDA

79.0M $, FY2025▼9.1% YoY

Operating margin

6% Industry: -8722▲34.4% YoY

P/E ratio

-14.7 Industry: 6▼360.7% YoY

Revenue & EBITDA

$882.0MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends

Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

102.7M 2025▲14.8% YoY

Capex

35.0M 2025▼14.3% YoY

Debt/equity ratio

0.2 Industry: 2▼NaN% YoY

R&D intensity

5.8%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-8.0%FY2026
Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals

Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

1.1

▼ 2.4%

2023

0.9

▼ 1.5%

2024

0.9

▼ 1.9%

2025

1.2

2031

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Available

Workplace health & safety policy

Available

19%
Independent Directors

3 out of 16 incl. management

Powered by illuminem

Overall score

85

Environment

70

Social

93

Governance

91

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available
image report
Available
image report
Available

Sustainability employees

Total sustainability employees

11+

    Available in
    Scale package

    Access
  • Email
  • Email